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Abstract. 
 
The perinucleolar compartment (PNC) is a 
unique nuclear structure localized at the periphery of 
the nucleolus. Several small RNAs transcribed by RNA 
polymerase III and two hnRNP proteins have been lo-
calized in the PNC (Ghetti, A., S. Piñol-Roma, W.M. 
Michael, C. Morandi, and G. Dreyfuss. 1992. 
 
Nucleic 
Acids Res.
 
 20:3671–3678; Matera, A.G., M.R. Frey, K. 
Margelot, and S.L. Wolin. 1995. 
 
J. Cell Biol.
 
 129:1181–
1193; Timchenko, L.T., J.W. Miller, N.A. Timchenko, 
D.R. DeVore, K.V. Datar, L. Lin, R. Roberts, C.T. 
Caskey, and M.S. Swanson. 1996. 
 
Nucleic Acids Res.
 
 24:
4407–4414; Huang, S., T. Deerinck, M.H. Ellisman, and 
D.L. Spector. 1997. 
 
J. Cell Biol.
 
 137:965–974). In this
report, we show that the PNC incorporates Br-UTP 
and FITC-conjugated CTP within 5 min of pulse label-
ing. Selective inhibition of RNA polymerase I does not 
appreciably affect the nucleotide incorporation in the 
PNC. Inhibition of all RNA polymerases by actinomy-
cin D blocks the incorporation completely, suggesting 
that Br-UTP incorporation in the PNC is due to tran-
scription by RNA polymerases II and/or III. Treatment 
of cells with an RNA polymerase II and III inhibitor in-
duces a significant reorganization of the PNC. In addi-
tion, double labeling experiments showed that poly(A) 
RNA and some of the factors required for pre-mRNA 
processing were localized in the PNC in addition to be-
ing distributed in their previously characterized nucleo-
plasmic domains. Fluorescence recovery after pho-
tobleaching (FRAP) analysis revealed a rapid turnover 
of polypyrimidine tract binding protein within the PNC, 
demonstrating the dynamic nature of the structure. To-
gether, these findings suggest that the PNC is a func-
tional compartment involved in RNA metabolism in 
the cell nucleus.
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T
 
he
 
 perinucleolar compartment (PNC)
 
1
 
 was first de-
scribed by the localization of the heterogeneous nu-
clear ribonucleoprotein I/polypyrimidine tract bind-
ing protein (hnRNP I/PTB) (Ghetti et al., 1992). This
subnuclear compartment is an irregularly shaped structure
with a large variability in size ranging from 0.25 to 1 
 
m
 
m in
diameter, and it is localized at the periphery of the nucleo-
lus. The PNC is predominantly found in transformed cells
and rarely observed in normal primary cells (Huang et al.,
1997). Cell cycle analysis using immunolabeling showed
that the PNC dissociates at the beginning of mitosis and
reforms at late telophase in the daughter nuclei. Time-
lapse observations of living cells transiently expressing
green fluorescent protein–tagged PTB (GFP–PTB) re-
vealed that the PNC is a dynamic structure exhibiting dis-
crete movements over time (Huang et al., 1997). Electron
microscopic examination of optimally fixed HeLa cells
demonstrated that the PNC is composed of multiple thick,
electron-dense strands, each measuring 
 
z
 
80–180 nm in di-
ameter (Huang et al., 1997). Some of these strands are in
direct contact with the surface of the nucleolus. Further-
more, deletion mutagenesis studies showed that at least
three RNA recognition motifs at either the COOH or NH
 
2
 
terminus of the PTB protein are required for it to be tar-
geted to the PNC, suggesting that RNA binding is neces-
sary for PTB to be localized in the PNC (Huang et al.,
1997). However, the function of the PNC and its relation-
ship to the transformed phenotype remains to be deter-
mined.
Thus far, several small RNAs transcribed by RNA poly-
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merase III (RNase MRP RNA, RNase
 
 
 
P
 
 
 
RNA, and hY
RNAs) (Matera et al., 1995; Lee et al., 1996) and two
hnRNP proteins, PTB (Ghetti et al., 1992) and CUG-BP/
hNab50 (Timchenko et al., 1996), have been identified in
the PNC. One of the hnRNP proteins in the PNC, PTB, is
a 57-kD RNA-binding protein that specifically binds pyri-
midine-rich sequences (Ghetti et al., 1992). PTB has been
shown to be involved in multiple cellular functions, includ-
ing pre-mRNA splicing (Patton et al., 1993; Singh et al.,
1995; Ashiya and Grabowski, 1997), splice site selection in
alternative pre-mRNA splicing (Lin and Patton, 1995;
Perez et al., 1997), RNA polyadenylation (Lou et al.,
1996), and translational regulation of certain viral RNA
transcripts (Hellen et al., 1994; Kaminski et al., 1995;
Witherell et al., 1995). PTB apparently participates in
these functions through the binding of pyrimidine-rich
RNA sequences. Therefore, PTB may serve as a bridge
between the pyrimidine tract containing RNAs and a vari-
ety of cellular factors to fulfill different cellular functions.
CUG-BP/hNab50, a second hnRNP protein localized to
the PNC, was initially isolated through a yeast two-hybrid
screen because of its interaction with the yeast hnRNP
protein Nab2p (Anderson et al., 1993). It was later re-
vealed that CUG-BP/hNab50 binds to the CUG triplet
repeats of myotonin protein kinase RNA, which is as-
sociated with myotonic dystrophy, an autosomal domi-
nant neuromuscular disease (Timchenko et al., 1996). The
CUG-BP/hNab50 protein binds polyadenylated RNA and
is distributed predominantly in the nucleoplasm as well as
enriched in a locus at the periphery of the nucleolus (Tim-
chenko et al., 1996). Double labeling experiments showed
that the perinucleolar localization of the protein coincides
with the PNC (Huang, S., and D.L. Spector, unpublished
result). More recently, the phosphorylation and intracellu-
lar distribution of CUG-BP/hNab50 were shown to be al-
tered in patients with myotonic dystrophy and in a myoto-
nin protein kinase knockout mouse (Robert et al., 1997).
However, it was not reported whether the distribution of
this protein in the PNC is affected by the change in phos-
phorylation of the protein. The role of CUG-BP/hNab50
in the PNC is not yet clear.
In addition to the above-described hnRNP proteins, sev-
eral RNA polymerase III transcripts (hY RNAs, RNase
 
 
 
P
RNA, and RNase MRP RNA) have also been localized to
the PNC (Matera et al., 1995). hY RNAs, which range in
size from 69–112 nucleotides, interact with the 60-kD Ro
protein to form Ro RNPs. Ro RNPs are present predomi-
nantly in the cytoplasm at 1% the level of ribosomes
(Wolin and Steitz, 1984), and their function is not known.
In spite of the presence of hY1, hY3, and hY5 RNAs, the
Ro protein itself was not found in the PNC (Matera et al.,
1995). RNase
 
 
 
P
 
 
 
RNA is involved in tRNA and preriboso-
mal RNA processing (for reviews see Altman, 1990; Clay-
ton, 1994). RNase
 
 
 
P
 
 
 
RNA is localized in the cytoplasm and
diffusely in the nucleoplasm in addition to being present in
the PNC (Darr et al., 1992; Matera et al., 1995; Jacobson et
al., 1997). When rhodamine-labeled RNase
 
 
 
P
 
 
 
RNA was in-
jected into the nucleus of NRK cells, the labeled RNA
rapidly accumulated in the nucleolus followed by a redis-
tribution into the nucleoplasm (Jacobson et al., 1997). The
transient association with the nucleolus suggests that
RNase
 
 
 
P
 
 
 
RNA may be processed and assembled into
RNPs or play a role in the nucleolus (Jacobson et al.,
1997). RNase MRP, another endoribonuclease, is involved
in preribosomal RNA processing (for review see Clayton,
1994). In situ hybridization and microinjection of labeled
RNase MRP RNA demonstrated that this RNA is local-
ized in the nucleolus and the PNC (Clayton, 1994; Jacob-
son et al., 1995; Matera et al., 1995). Not all RNAs tran-
scribed by RNA polymerase III are detected in the PNC.
In situ hybridization with specific probes to hY4, 5S
rRNA, and U6 snRNA did not reveal hybridization sig-
nals in the PNC (Matera et al., 1993, 1995). The signifi-
cance of the accumulation of several RNA polymerase III
transcripts in the PNC is presently unknown.
In this report, we demonstrate that the PNC is structur-
ally distinct from the nucleolus and forms a reticulated
mesh on a portion of the nucleolar surface. The PNC in-
corporates Br-UTP and FITC-CTP after a short pulse us-
ing permeabilized cells, suggesting that the PNC is in-
volved in transcription. The structure of the PNC is altered
upon the inhibition of RNA synthesis in cultured cells,
suggesting that the integrity of the PNC reflects its tran-
scriptional activity. Immunolabeling and in situ hybridiza-
tion have shown that several pre-mRNA processing fac-
tors, including splicing factors (snRNPs and SC35) and a 3
 
9
 
end processing factor (poly(A) binding protein II [PAB
II]), and poly(A) RNA are present in the PNC. In addi-
tion, fluorescence recovery after photobleaching (FRAP)
analysis has shown that the hnRNP protein, PTB, turns
over rapidly in the PNC. Together, these findings suggest
that the PNC is a dynamic subnuclear structure that is in-
volved in RNA metabolism in transformed cells.
 
Materials and Methods
 
Cell Culture
 
HeLa cells were grown to subconfluence on 22 
 
3 
 
22-mm glass coverslips
in 35-mm Petri dishes in Dulbecco’s modified Eagle’s minimum essential
medium (DMEM) supplemented with 10% fetal calf serum (FCS)
(GIBCO-BRL, Life Technologies, Inc., Rockville, MD). The inhibition of
RNA polymerase I transcription was achieved by the addition of actino-
mycin D (0.04 
 
m
 
g/ml for 3 h) (Perry, 1963). The inhibition of RNA poly-
merase II transcription was achieved by the addition of 
 
a
 
-amanitin (50 
 
m
 
g/
ml for 5 h) (Kedinger et al., 1970; Lindell et al., 1970) or 5,6-dichloro-
1-
 
b
 
-
 
d
 
-ribofuranosylbenzimidazole (DRB) (25 
 
m
 
g/ml for 3 h) (Sehgal et
al., 1976) to the culture medium. Transcription inhibition was reversed
when DRB-containing medium was removed from cells and replaced with
fresh medium. Cycloheximide (Sigma Chemical Co., St. Louis, MO) was
added at 100 
 
m
 
g/ml for 5 h to inhibit protein synthesis and RNA poly-
merase I activity (Higashi et al., 1968; Willems et al., 1969; O’Keefe et al.,
1994).
 
Three-dimensional Reconstruction of the PNC by 
Electron Microscopy
 
Transiently expressed GFP–PTB (Huang et al., 1997) was used as a
marker to indicate the localization of the PNC. The corresponding nuclear
region identified by fluorescence of the GFP–PTB fusion protein was ex-
amined by electron microscopy. Specifically, transfected cells were seeded
onto gridded glass coverslips. 12 h after transfection, cells were fixed in
4% paraformaldehyde with 0.05% glutaraldehyde in PBS, and cells that
showed the PNC were quickly photographed using an epifluorescence mi-
croscope (model FXA; Nikon, Inc., Melville, NY) equipped with a cooled
CCD camera (1320 
 
3 
 
1035, 6.7 
 
m
 
m pixel size) (SenSys; Photometrics, Inc.,
Tuscon, AZ) using Oncor Image software. Subsequently, cells were fixed
in 2% glutaraldehyde for 20 min and washed in PBS and 0.1 M cacodylate
buffer, pH 7.4. Cells were then postfixed in 1% osmium tetroxide contain- 
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ing 0.15% ferrous cyanide in 0.1 M cacodylate buffer, pH 7.4, for 1 h, de-
hydrated by incubation in a series of ascending concentrations of ethanol,
and embedded in Epon/araldite at 60
 
8
 
C for 48 h. Serial 80-nm-thick sec-
tions were poststained with uranyl acetate–lead citrate, mounted on slot
grids, and examined at 80 keV with a transmission electron microscope
(model 100CX; JEOL U.S.A., Inc., Peabody, MA). The same cells photo-
graphed at the fluorescence microscopic level were located, and serial im-
ages of the nuclear regions that corresponded to the PNCs were recorded.
Outlines of the nucleoli and PNCs were hand traced on 11” 
 
3 
 
14” photo-
graphic prints and digitized using a digitizing tablet and a software pro-
gram described by
 
 
 
Young et al. (1987). The section planes were aligned,
and volumes were surface-rendered using the programs SYNU and
SYNU-render as previously described by Hessler et al. (1992).
 
Nuclear Extraction
 
Cells were extracted following a modification of a protocol described by
Fey et al. (1986). Subconfluent cells grown on glass coverslips were rinsed
with PBS and incubated at 4
 
8
 
C for 10 min in CSK buffer (100 mM NaCl,
300 mM sucrose, 10 mM Pipes, pH 6.8, 3 mM MgCl
 
2
 
, 1 mM PMSF, and 2
mM vanadyl ribonucleoside complex) containing 0.5% Triton X-100 (vol/
vol). Cells were incubated at 4
 
8
 
C for 5 min in the CSK buffer containing
250 mM ammonium sulfate and 0.5% Triton X-100, treated with DNAse I
in CSK buffer with 50 mM NaCl for 30 min at 37
 
8
 
C or room temperature,
and finally fixed in 2% paraformaldehyde in PBS.
 
Transfection
 
Expression constructs were transiently transfected into HeLa cells by
electroporation (Spector et al., 1997). Subconfluent cells in a 100-mm cul-
ture dish were trypsinized and collected in DMEM supplemented with
10% FBS. Cells were then mixed with 20 
 
m
 
g of DNA including 7 
 
m
 
g target
DNA and 13 
 
m
 
g sheared salmon sperm DNA. 280 
 
m
 
l of cell–DNA mixture
was electroporated in a Bio-Rad electroporator (Hercules, CA) at 260 V
and 960 
 
m
 
F. Cells were subsequently seeded onto glass coverslips in 35-
mm Petri dishes and were grown for either 7 or 24 h.
 
FRAP
 
Living cell studies were performed using a 35-mm Petri dish with a cover-
slip attached to the bottom. Transfected cells were grown on the coverslip
for 24 h and observed using an inverted confocal laser-scanning micro-
scope (model 410; Carl Zeiss, Inc., Thornwood, NY). An initial image was
acquired, and a FRAP macro was used to photobleach a designated area
of the nucleus. The photobleaching was accomplished using the 488-nm
argon laser at 50% of its full power (25 mW) for 20 s. Immediately after
the bleaching process, an averaged image was obtained. Multiple images
were subsequently acquired within 5 min after bleaching, as indicated in
Fig. 6.
 
Nucleotide Incorporation Assay
 
The transcription assay was modified from published studies (Jackson et
al., 1993; Wansink et al., 1993). At 8 or 24 h after transfection, cells were
rinsed once with PBS and once with a Tris-glycerol buffer (20 mM Tris-
HCl, pH 7.4, 5 mM MgCl
 
2
 
, 25% glycerol, 0.5 mM PMSF, and 0.5 mM
EGTA). Cells were then permeabilized in the same buffer containing 5
 
m
 
g/ml digitonin at room temperature for 3 min. Subsequently, cells were
incubated in transcription cocktail (100 mM KCl, 50 mM Tris-HCl, pH
7.4, 5 mM MgCl
 
2
 
, 0.5 mM EGTA, 25% glycerol, 1 mM PMSF, 2 mM ATP,
0.5 mM CTP, 0.5 mM GTP, 0.2 mM Breakup or 0.4 mM FITC-CTP, and 1
U/ml RNasin) for 5 min at 37
 
8
 
C. At the end of the transcription reaction,
cells were gently rinsed three times with PBS and then fixed in 2% formal-
dehyde in PBS. Transcription inhibition was achieved by adding the corre-
sponding drugs to the permeabilization buffer and transcription cocktail.
 
Immunolabeling
 
Subconfluent HeLa cells grown on glass coverslips were extracted with
CSK buffer containing 0.3% Triton X-100 for 3 min and fixed in freshly
made 2% formaldehyde in PBS for 15 min. Cells were washed three times
for 10 min each in PBS, and coverslips were incubated with primary anti-
body for 1 h at room temperature. Antibodies used in this study included
anti-PTB primary antibody, SH54 (Huang et al., 1997), at a dilution of
1:300, anti-Sm antibody (Lerner and Steitz, 1979) at a dilution of 1:1,000,
anti-B
 
0
 
 at a dilution of 1:10 (Habets et al., 1987, 1989), antifibrillarin
(Sigma Chemical Co.) (Ochs et al., 1985) at a dilution of 1:5, anti-SC35 at
a dilution of 1:1,000 (Fu and Maniatis, 1990), anti–PAB II at a dilution of
1:10 (Krause et al., 1994), or anticoilin at a dilution of 1:100 (Andrade et
al., 1993). Cells were rinsed in PBS, incubated with Texas red–conjugated
goat anti–human, FITC- or Texas red–conjugated goat anti–mouse, or
Texas red goat anti–rabbit antibody at a dilution of 1:100 for 1 h at room
temperature, and then washed three times for 10 min each in PBS. The
coverslips were mounted onto glass slides with mounting medium contain-
ing 90% glycerol in PBS with 1 mg/ml paraphenylenediamine as an anti-
fade agent. The mounting medium was adjusted to pH 8.0 with 0.2 M bi-
carbonate buffer (Spector et al., 1997). Cells were examined with a
microscope (model FXA; Nikon, Inc.) equipped with epifluorescence and
differential interference contrast optics. Images were captured by a cooled
CCD camera (1320 
 
3 
 
1035, 6.7 
 
m
 
m pixel size) (SenSys; Photometrics, Inc.)
using Oncor Image software.
 
Results
 
The PNC Forms a Reticulated Mesh Associated with a 
Portion of the Nucleolar Surface
 
Previous examination of thin-sectioned and optimally
fixed HeLa cells revealed that the PNC is an electron-
Figure 1. Correlative fluorescent and electron microscopic im-
ages of the PNC in the same cells show that the PNC is distinct
from and more electron-dense than the nucleolus. HeLa cells
transiently expressing GFP–PTB were photographed using a Sen-
Sys cooled CCD camera (left column) and subsequently fixed,
embedded, thin sectioned, and poststained. The same cell was
sought, and the nuclear regions corresponding to the PNC, ob-
served at the light microscopic level, were correlated at the elec-
tron microscopic level (right column). Bar, 3 mm. 
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dense structure composed of thick strands, some of which
are in direct contact with the surface of the nucleolus
(Huang et al., 1997). We sought to determine if these thick
strands are interconnected and if they form a higher order
structure. To resolve the three-dimensional organization
of the PNC at high resolution, PNCs in serial thin sections
of optimally fixed HeLa cell nuclei were examined by elec-
tron microscopy (Materials and Methods). The sections
were poststained with uranyl acetate–lead citrate, and the
PNC was readily distinguishable from the nucleolus under
these conditions of specimen preparation. The PNC was
also identified by correlating the cell sections to a fluores-
cent image of the same cell in which the expression of
GFP–PTB (Huang et al., 1997) marked the PNC (Fig. 1).
The PNC appeared to be more electron dense than the nu-
cleolus and formed thick strands, some of which intimately
Figure 2. Three-dimensional
computer rendering of the
PNC from serial section elec-
tron microscopy reveals that
the PNC forms a highly inter-
connected reticulated mesh-
work on a portion of the nu-
cleolar surface (stereo image
pairs). Three examples illus-
trate the variability of the as-
sociation between the PNC
and the nucleolus among dif-
ferent cells. The green repre-
sents the PNC, and the purple
represents the nucleolus. 
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associate with the nucleolus. Images of serial sections were
aligned, and three-dimensional models were reconstructed
using the programs SYNU and SynuRender (Hessler et
al., 1992) (Fig. 2). Such analysis has revealed that the PNC
is a highly interconnected and reticulated mesh associated
with a portion of the nucleolar surface. However, there is
considerable variability in the shape, size, and the relation-
ship of the PNC with the nucleolus. In some cells, the PNC
is mostly positioned on the surface of the nucleolus (Fig. 2
 
A
 
), while in others, the PNC extends into the nucleolus
like a plug (Fig. 2 
 
B
 
). Occasionally, a portion of the nucle-
olus extends into the PNC (Fig. 2 
 
C
 
). This variability may
represent the dynamic range of PNC:nucleolus interrela-
tionships.
 
The PNC Is Actively Involved in Transcription
 
Based on the abundance of RNAs and RNA-binding pro-
teins in the PNC, we were interested in examining if this
subnuclear compartment is involved in transcription. In
situ Br-UTP incorporation experiments were performed
to evaluate the transcriptional activity in the PNC. Cells
transiently expressing GFP–PTB, which marks the PNC,
were briefly permeabilized and incubated in a transcrip-
tion cocktail containing Br-UTP using a modified protocol
based on the work of Wansink et al. (1993) and Jackson et
al. (1993). Cells were then fixed, and the nuclear sites of
Br-UTP incorporation were detected by immunolabeling
with a monoclonal antibody that specifically recognizes
the Br epitope. Simultaneous detection of the incorpora-
tion sites (
 
red signal
 
) and the PNC, marked by GFP–PTB
(
 
green signal
 
), demonstrates that the PNC coincides with
sites of Br-UTP incorporation (Fig. 3, 
 
top row
 
). In fact, the
Br-UTP incorporation is often more prominent in the
PNC than in most of the nucleoplasm. However, the size
and shape of the sites of Br-UTP incorporation often do
not completely overlap with the PNC. The incorporation
was inhibited when it was performed at 4
 
8
 
C and was not
detected in the presence of RNase A (data not shown),
suggesting that the nucleotides are incorporated into the
RNA in an energy-dependent reaction. The nucleotide in-
corporation could result from either transcription or post-
transcriptional modification of nascent RNA, including
editing and uridinylation. It has previously been shown
that U is posttranscriptionally added to certain small RNA
polymerase III transcripts, including RNase MRP RNA
(Hashimoto and Steitz, 1983; Yuan et al., 1989), which is
found in the PNC. To determine the nature of the Br-UTP
incorporation in the PNC, we examined whether the incor-
poration is DNA dependent and whether the PNC incor-
porates nucleotides other than Br-UTP. We found that the
Br-UTP incorporation in the PNC and the entire nucleus
(Fig. 3, 
 
second row
 
) was inhibited in the presence of a high
concentration of actinomycin D (50 
 
m
 
g/ml) (Perry, 1963),
which intercalates into DNA and prevents it from being
used as a transcription template. Furthermore, addition of
FITC-CTP to the transcription cocktail resulted in an in-
corporation in the PNC that is similar to the incorporation
of Br-UTP (Fig. 3, 
 
third row
 
). These findings further dem-
onstrate that the nucleotide incorporation into the PNC is
the consequence of transcription.
To identify which RNA polymerase is involved in the
Br-UTP incorporation in the PNC, transcription inhibitors
that preferentially inhibit different RNA polymerases
were added individually to the transcription cocktail. To
inhibit RNA polymerase I activity, two alternative ap-
proaches were used. Actinomycin D, which inhibits RNA
polymerase I at low concentration (Perry, 1963), was
added, and the concentration used was titrated such that
the nucleolar incorporation of Br-UTP was significantly
reduced and the nucleoplasmic incorporation did not ex-
hibit a detectable change (Fig. 3, 
 
fourth row
 
). At this con-
centration of actinomycin D, no significant change was ob-
served in the Br-UTP incorporation in the PNC (Fig. 3,
 
fourth row
 
). Alternatively, cells were pretreated with cy-
cloheximide (100 
 
m
 
g/ml) for up to 5 h before the Br-UTP
incorporation assay. Cycloheximide has been shown to in-
hibit protein synthesis as well as RNA polymerase I tran-
scription by limiting essential labile factors (Higashi et al.,
1968; Willems et al., 1969; O’Keefe et al., 1994). The indi-
rect inhibition of RNA polymerase I by inhibiting protein
synthesis enables cycloheximide to circumvent the poten-
tial accessibility problem that other drugs might have. The
treatment of cycloheximide inhibited most of Br-UTP in-
corporation in the nucleolus but did not appreciably alter
the incorporation in the PNC (Fig. 3, 
 
fifth row
 
). The simi-
lar results obtained by using two different inhibitory
mechanisms suggests that RNA polymerase I is unlikely to
be responsible for the Br-UTP incorporation in the PNC.
To examine whether RNA polymerases II and/or III are
involved, we added 
 
a
 
-amanitin into the transcription cock-
tail. 
 
a
 
-Amanitin specifically and selectively inhibits RNA
polymerase II at a low concentration of 50 
 
m
 
g/ml (Stripe
and Fiume, 1967; Weinmann et al., 1975) and inhibits both
polymerases II and III at a high concentration of 300 
 
m
 
g/
ml (Weinmann and Roeder, 1974). Surprisingly, the addi-
tion of 
 
a
 
-amanitin at either the low or high concentration
did not significantly change the Br-UTP incorporation in
the PNC (Fig. 3, 
 
bottom row
 
), despite a significant reduc-
tion in nucleoplasmic incorporation. Since the Br-UTP in-
corporation in the PNC is due to the transcription that oc-
curs within the 5 min of pulse labeling as described above,
and since we have ruled out the involvement of RNA
polymerase I transcription, it is therefore most likely that
RNA polymerase II and/or III are responsible for the syn-
thesis of nascent RNA in the PNC. A reasonable explana-
tion for a lack of transcription inhibition may be the inabil-
ity of 
 
a
 
-amanitin to gain access into the PNC.
 
The Structural Integrity of the PNC Is Sensitive to 
Transcriptional Inhibition
 
To examine if inhibition of transcription would influence
the structure of the PNC in vivo, HeLa cells were treated
with 
 
a
 
-amanitin at 50 
 
m
 
g/ml for 5 h. The structure of the
PNC showed a marked alteration after inhibition of RNA
polymerase II (Fig. 4, 
 
A
 
 and 
 
C
 
). The PNC is no longer a
compact structure with clear boundaries after 
 
a
 
-amanitin
treatment. PTB (
 
green
 
) seems to extend from what ap-
pears to be the original site of the PNC into the nucleo-
plasm and, in many cases, forms a series of dots in a ro-
sette with a hollow center (Fig. 4 
 
A
 
, 
 
arrow
 
 and
 
 arrowhead
 
;
area at the 
 
arrow
 
 is enlarged in the 
 
inset
 
). When double la-
beled with the anti-Sm antibody (
 
red
 
), a colocalization was 
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observed between the original sites of the PNC and sn-
RNPs. Interestingly, the extended rosette-shaped dots sur-
round the round snRNP clusters (Fig. 4 
 
C
 
, 
 
arrow
 
 and 
 
ar-
rowhead
 
; area at the 
 
arrow
 
 is enlarged in the 
 
inset
 
). Such
alterations appear to form a gradient that decreases with
distance from the original locus (the strongly stained re-
gion) of the PNC. In contrast, inhibition of RNA poly-
merase II transcription exerts little to no effect on the dif-
fuse nuclear distribution pattern of PTB in cells that do
not have a PNC (Fig. 4 
 
D
 
), demonstrating that the ob-
served alteration is specific to the PNC. Similar changes
were also observed when cells were treated with DRB, an-
other RNA polymerase II inhibitor that inhibits a major
nuclear Ser/Thr protein kinase, casein kinase II (Sehgal et al.,
1976; Zandomeni and Weinmann, 1984). These changes
were reversible after cells were grown in drug-free me-
Figure 3. The PNC actively
incorporates Br-UTP in a
transcription assay using per-
meabilized cells. The left
panels are images of PNCs,
marked by expression of
GFP–PTB. The middle pan-
els represent the labeled nu-
cleotide incorporation pat-
tern in the same cells. The
right panels are overlays
from the first two panels.
Most PNCs incorporate Br-
UTP above the basal level of
incorporation in the nucleo-
plasm (top row, arrows). In
some cases, the incorporation
of Br-UTP only occurs in
part of the PNC. When tran-
scription by all RNA poly-
merases are inhibited in the
presence of a high concentra-
tion of actinomycin D (50 mg/
ml), Br-UTP incorporation
is not observed in either
the  PNC or the nucleus (sec-
ond row). The PNC also in-
corporates FITC-CTP (third
row, arrow). Addition of a
low concentration of actino-
mycin D (fourth row, arrow)
or pretreatment using cyclo-
heximide (100 mg/ml) for 3 h
before the assay (fifth row,
arrow), both of which selec-
tively inhibit RNA poly-
merase I transcription, do not
significantly affect the Br-UTP
incorporation in the PNC.
Surprisingly, when RNA poly-
merases II and III are in-
hibited by the addition of
a-amanitin (300 mg/ml), the
incorporation of Br-UTP in
the PNC is also not obviously
changed (bottom row, arrow).
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dium for 2 h (data not shown), indicating that the observed
alteration in the structure of the PNC is unlikely to be the
result of cell death. These findings show that the integrity
of the PNC is dependent upon the transcriptional activity
of RNA polymerase II.
Examination of another hnRNP protein, CUG-BP/
hNab50, during transcription inhibition using monoclonal
antibody 3B1 (Timchenko et al., 1996), which specifically
recognizes CUG-BP/hNab50, revealed a similar reorgani-
zation of the PNC. However, in contrast to PTB, most of
the soluble nucleoplasmic CUG-BP/hNab50 is localized to
the cytoplasm when RNA polymerase II transcription is
inhibited by a-amanitin. This finding suggests that CUG-
BP/hNab50 may belong to the group of hnRNPs that shut-
tle between the nucleus and cytoplasm in a transcription-
dependent manner (for review see Siomi and Dreyfuss,
1997). However, the fraction of CUG-BP/hNab50 that is
present in the PNC remains in the nucleus and is colocal-
ized with PTB in the structurally altered PNC (Fig. 4, G–I).
In cells that do not contain a PNC, CUG-BP/hNab50 is not
detected in the nucleus upon transcription inhibition (data
not shown).
When cells in culture were treated for 2–5 h with actino-
mycin D at a concentration that either selectively inhibits
RNA polymerase I (0.04 mg/ml) or all RNA polymerases
(10 mg/ml) (Perry, 1963), the PNC was no longer detected
by immunolabeling using monoclonal antibodies SH54 or
3B1 (data not shown). However, when cells were treated
with cycloheximide (a protein synthesis inhibitor) at 100
mg/ml for up to 5 h, little change was observed in the struc-
ture of the PNC (data not shown). Since cycloheximide
also inhibits RNA polymerase I activity by inhibiting the
synthesis of necessary labile factors (Higashi et al., 1968;
Willems et al., 1969; O’Keefe et al., 1994), the resistance to
cycloheximide treatment suggests that the structural integ-
rity of the PNC is not dependent on RNA polymerase I
transcription or protein synthesis. This finding is consis-
tent with the observation in permeabilized cells that the
Br-UTP incorporation in the PNC does not reflect RNA
polymerase I transcription. As previous studies showed
that treatment with actinomycin D causes nucleolar frag-
mentation (Reynolds et al., 1964; Ochs et al., 1985), it is
not clear whether the disappearance of the PNC after acti-
nomycin D treatment is due to other effects of the drug
rather than the inhibition of RNA polymerase I activity.
The PNC Contains Poly(A) RNA and Pre-mRNA 
Processing Factors
Incorporation of Br-UTP together with the presence of
RNA transcripts and hnRNP proteins in the PNC suggest
that the PNC is involved in RNA metabolism. To further
Figure 4. The structure of the
PNC changes upon transcrip-
tion inhibition by a-amanitin
(an inhibitor of RNA poly-
merase II and/or III) in cells
transiently expressing GFP–
PTB (A). When double la-
beled with the Sm antibody
(B), the extended PNC ap-
pears to form rosettes sur-
rounding the round Sm clus-
ters (C, inset). This change
was not observed in cells that
do not contain a PNC (D–F),
suggesting that the change is
specific to a reorganization of
the PNC. When the distribu-
tion of GFP–PTB (G) and
CUG-BP/hNab50 (H) was
compared upon transcription
inhibition by a-amanitin, a
similar reorganization of the
PNC in the nucleus was ob-
served for both hnRNP pro-
teins (G–I) in spite of the fact
that the majority of the
CUG-BP/hNab50 protein be-
comes predominantly local-
ized in the cytoplasm (H).
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investigate the function of the PNC, we examined it for the
presence of polyadenylated RNA, pre-mRNA splicing fac-
tors, and a 39 end processing factor. In situ hybridization in
HeLa cells using a biotinylated oligo (dT)50 probe (Huang
et al., 1994) revealed that poly(A) RNA is present in the
PNC in addition to being distributed throughout the nu-
cleus in a diffuse and speckled pattern (Fig. 5, top row).
The labeling of the poly(A) RNA in some PNCs is at a
similar intensity as the larger nuclear speckles. In other
PNCs, the labeling intensity of poly(A) RNA is indistin-
guishable from the diffuse nuclear labeling (data not
shown).
Immunolabeling of pre-mRNA splicing factors includ-
ing U2 snRNPs (Habets et al., 1987, 1989), SC35 (Fu and
Figure 5. Pre-mRNA processing
factors are localized in the PNC.
HeLa cells transiently expressing
GFP–PTB (left column, arrows indi-
cating the PNC) were immunola-
beled with antibodies specifically
recognizing several pre-mRNA pro-
cessing factors as indicated (middle
column, arrows showing the same
nuclear regions containing these
factors). The right column shows
the colocalization of the PNC and
the RNA processing factors. P80-
coilin (bottom row), as a negative
control, is not detected in the PNC.
Bar, 10 mm.Huang et al. Perinucleolar Compartment Transcription 43
Maniatis, 1990), and a 39 end processing factor, PAB II
(Krause et al., 1994), showed that these factors are present
in the PNC in addition to their previously characterized
sites of localization (Fig. 5). However, the labeling inten-
sity varies among PNCs. To exclude the possibility that the
labeling in the PNC is simply due to the diffuse nuclear
staining of these factors, we examined the localization of
another diffusely distributed nuclear component, p80 coi-
lin. Coilin, an 80-kD protein, is diffusely distributed in the
nucleus in addition to being present in coiled bodies (for
reviews see Brasch and Ochs, 1992; Lamond and Carmo-
Fonseca, 1993; Gall et al., 1995; Roth, 1995). When coilin
was localized with anticoilin antibody (Andrade et al.,
1993), no staining of PNCs was observed (Fig. 5, bottom
row). The presence of RNA processing factors and
poly(A) RNA in the PNC is consistent with the idea that
the PNC is a site of transcription and that RNA poly-
merase II is one of the transcription systems involved.
Furthermore, these findings suggest that posttranscrip-
tional processing of certain transcripts may also occur in
the PNC.
PTB Turns Over Rapidly in the PNC
To understand the dynamics of the hnRNP proteins in the
PNC, we used FRAP to examine the turnover of GFP–
PTB in the PNC (see Materials and Methods). Cells trans-
fected with the GFP–PTB construct were examined using
a confocal laser-scanning microscope (Carl Zeiss, Inc.,
Thornwood, NY). Cells with two PNCs were chosen so
that one of them served as a marker to monitor the speci-
ficity of bleaching and the stability of the focal plane. An
initial image was captured before photobleaching. The
PNC was photobleached for 20 s by exposure to the 488-
nm laser line using the line scanning mode. An averaged
image was obtained immediately after photobleaching fol-
lowed by a series of images at different time points (Fig. 6,
top and middle rows). The photobleaching resulted in a
nearly complete loss of the GFP–PTB labeling in the tar-
geted PNC. The bleaching was specific since the neighbor-
ing PNC, which was separated by a few micrometers, was
not affected. 25 s after the bleaching, the GFP–PTB began
to reappear in the PNC, and the fluorescent intensity in
the PNC recovered to a similar level as before the bleach-
ing process within 5 min. The rapid recovery suggests that
the unbleached GFP–PTB in the nucleoplasm quickly en-
ters the PNC. Moreover, the quantitatively large degree of
recovery indicates that GFP–PTB is highly mobile in the
PNC and that there is not a large immobile fraction of the
protein. To exclude the possibility that the recovery of
the GFP–PTB labeling in the PNC is due to a spontaneous
fluorescence recovery of GFP–PTB, fixed cells expressing
Figure 6. FRAP studies re-
veal the dynamics of PTB in
the PNC. GFP–PTB was
transiently expressed in
HeLa cells. The fluorescence
of the bleached PNC in the
living cell (top and middle
rows) begins to recover al-
most immediately after the
photobleaching. The fluores-
cence intensity in the PNC
reaches a similar intensity as
compared with before pho-
tobleaching within 5 min,
suggesting that PTB under-
goes a rapid turnover in the
PNC. However, in fixed cells
(bottom row), when the
fluorescent PNC is photo-
bleached (arrowheads), the
fluorescence in the PNC does
not recover even after 5 min.
This finding demonstrates
that PTB undergoes a rapid
turnover in the PNC. Bar,
10  mm.The Journal of Cell Biology, Volume 143, 1998 44
GFP–PTB were examined by FRAP in an identical man-
ner (Fig. 6, bottom row). Again, a complete photobleach-
ing of the labeled PNC was achieved without affecting an
adjacent PNC. However, recovery of the fluorescence in
the bleached PNC was not observed up to 30 min. The re-
sult of the control experiment confirmed that the fluores-
cence recovery observed in living cells is most likely due to
the rapid turnover of PTB in the PNC. The rapid turnover
of this hnRNP protein in the PNC is consistent with the
dynamic nature of a transcription site with regard to RNA
synthesis and subsequent transport of processed product
away from the transcription site.
The PNC Is Associated with an Insoluble Fraction of 
the Nucleus
To determine the solubility of the PNC, HeLa cells were
first extracted with 0.5% Triton X-100, followed by treat-
ment with 250 mM ammonium sulfate and subsequent
DNase I digestion (Fey et al., 1986). Cells were then fixed
and immunostained with SH54, a previously characterized
monoclonal antibody that specifically recognizes PTB in
the PNC (Huang et al., 1997), and human antifibrillarin
antibody (Sigma Chemical Co.) (Ochs et al., 1985), which
marks the nucleolus. PTB in the PNC remains detectable
at the periphery of the nucleolus after the extraction pro-
cedure (Fig. 7 A, arrowhead). The PNCs in these prepara-
tions appear to be more rounded and smaller in size than
in unextracted cells. In contrast to the pool of PTB in the
PNC, the diffusely localized nucleoplasmic pool of PTB
decreased significantly upon extraction, concomitant with
an increase in the staining of the protein in the nucleolus
(Fig. 7 A), which was identified by immunolabeling with
the antifibrillarin antibody (Fig. 7 B). To examine whether
PTB in the nucleolus is derived from the PNC, Detroit 551
cells (normal human fibroblasts), only 2% of which display
visible PNCs, were prepared using the same protocol. A
similar relocation of nucleoplasmic PTB to the nucleolus
was observed in all of the cells in spite of the absence of
the PNC in these cells (Fig. 7 D). The simplest explanation
is that the extraction leads to the release of PTB from
binding to components that are responsible for its diffuse
nuclear distribution pattern, and it is then relocated into
the nucleoli. These observations demonstrate that the
PNC-associated PTB represents a less soluble fraction
than the diffuse nuclear population of this protein.
Discussion
In the present study, we have shown that the PNC actively
incorporates Br-UTP and FITC-CTP in a transcription as-
say using permeabilized cells. Many studies have used this
assay to investigate transcription patterns in the cell nu-
cleus (Hozak et al., 1994; Aoki et al., 1997; Fay et al., 1997;
Neugebauer and Roth, 1997) since its initial establishment
(Jackson et al., 1993; Wansink et al., 1993). Our observa-
tion that the PNC actively incorporates labeled nucle-
otides in a DNA-dependent manner after 5 min of pulse
labeling suggests that the PNC is a site of transcription. In-
hibition of RNA polymerase I either by addition of actino-
mycin D in the transcription cocktail or by pretreatment of
cells with cycloheximide does not affect the Br-UTP incor-
poration, indicating that transcription of nascent RNA in
the PNC is unlikely to involve RNA polymerase I. This
finding is consistent with the report by Matera et al. (1995)
that 28S rRNA was not detected in the PNC using in situ
hybridization and our previous findings that fibrillarin,
which is required for rRNA processing, is not present in
the PNC (Huang et al., 1997). RNA polymerases II and/or
III may be responsible for the transcription occurring in
Figure 7. The PNC is associ-
ated with the less soluble
fraction of the nucleus. PTB
labeling of the PNC is main-
tained after an extraction us-
ing detergent, high salt, and
DNAse treatment (A, arrow-
heads). In contrast, the ma-
jority of the diffuse nuclear
PTB labeling decreases sig-
nificantly accompanied by an
increased labeling of PTB in
the nucleolus (A). Nucleoli
labeled with an antibody spe-
cifically recognizing fibril-
larin do not show a signifi-
cant change (B). DNA in the
extracted cells is no longer
detectable when stained
with DAPI (C and F). PTB
in Detroit 551 cells that do
not contain a PNC also show
a similar relocalization of
the PTB protein (D) into the
nucleolus (marked by immu-
nolabeling of fibrillarin in E)
upon extraction. Bar, 10 mm.Huang et al. Perinucleolar Compartment Transcription 45
the PNC, although it is not clear at the present time
whether both polymerases are involved. Consistent with
this suggestion are the findings that poly(A) RNA and
small RNAs transcribed by RNA polymerase III, includ-
ing hY RNAs, RNase MRP RNA, and RNase P RNA
(Matera et al., 1995), are detected in the PNC. Further-
more, immunocytochemical labeling revealed that RNA
processing factors, including snRNPs, SC35, and PAB II,
are present in the PNC. SnRNPs and SC35 primarily par-
ticipate in the processing of RNA polymerase II tran-
scripts, and PAB II binds to polyadenylated RNA tran-
scribed by both RNA polymerase II and III. It has become
increasingly evident from morphological and biochemical
studies that RNA transcription and processing are spa-
tially and temporally linked (Beyer et al., 1980; Beyer and
Osheim, 1988; Jiménez-García and Spector, 1993; Xing
and Lawrence, 1993; Zhang et al., 1994; Bauren et al.,
1996; Huang and Spector, 1996; Du and Warren, 1997;
Kim et al., 1997; McCracken et al., 1997; Misteli et al.,
1997; Zeng et al., 1997). The presence of RNA processing
factors in the PNC supports the notion that the PNC is a
site of transcription and suggests that it may also be in-
volved in RNA processing. However, we cannot exclude
the possibility that the rapid accumulation of newly syn-
thesized RNA transcripts in the PNC may be the result of
transcription elsewhere in the nucleus and the subsequent
very rapid translocation of these transcripts to the PNC.
As described in a previous study by Matera et al. (1995),
the chromosome segment that encodes two of the hY
RNAs only showed an occasional association with the
PNC. In addition, the La protein known to be at least tran-
siently associated with newly synthesized RNA poly-
merase III transcripts was not detected in the PNC using
immunocytochemical labeling (Matera et al., 1995). Very
recently, two other nuclear bodies were found to incorpo-
rate tagged nucleotides after a short pulse labeling (La-
Morte et al., 1998; Pombo et al., 1998). Promyelocytic leu-
kemia (PML) bodies and coiled bodies rapidly accumulate
FITC-UTP upon microinjection into cells, and PML bod-
ies were also shown to contain a transcription factor,
cAMP-regulated enhancer binding protein (CREB) bind-
ing protein (LaMorte et al., 1998). In addition, the poly-
morphic interphase karyosomal association (PIKA) domain
was shown to be associated with specific chromosomes
and to also be active in transcription (Pombo et al., 1998).
These observations, together with our finding that the
PNC accumulates nascent RNA, suggest that transcription
may be spatially regulated in subnuclear compartments.
Further studies will identify transcripts that are synthe-
sized and/or processed in the PNC.
Based upon the extraction behavior and structural alter-
ations during transcription inhibition, two populations of
the hnRNP proteins PTB and CUG-BP/hNab50 were
identified in the HeLa cell nucleus. One population is dif-
fusely distributed throughout the nucleoplasm, and the
other population is enriched in the PNC with a much
higher fluorescent intensity, implying a higher protein
concentration. The PNC-associated hnRNP proteins are
linked with the less soluble fraction of the nucleus and re-
main associated with the structurally altered PNC during
transcription inhibition, whereas the diffusely distributed
nuclear populations are removed by the extraction, and
CUG-BP/hNab50 is relocated to the cytoplasm during
transcription inhibition. These differences suggest that the
two populations of hnRNP proteins, the PNC-associated
and the diffuse nucleoplasmic, each may interact with a
different set of cellular constituents. Since the PNC is pre-
dominantly observed in cells with a transformed pheno-
type, we speculate that the PNC-associated hnRNP pro-
teins may be complexed with cellular components that are
altered in terms of their expression or modification in
transformed cells. Future studies will focus on the isolation
and identification of these constituents.
An increasing number of nuclear bodies or inclusions
have been described in recent years from cells or tissues
that have altered physiology or are derived from various
disease-related samples. For example, coiled bodies, round
and electron-dense structures, are often observed in trans-
formed and cancer cell lines (Spector et al., 1992; Ochs et
al., 1994). Coiled bodies contain snRNPs, U3 snoRNP,
fibrillarin, NOPP140, and p80-coilin (for reviews see La-
mond and Carmo-Fonseca, 1993; Gall et al., 1995; Roth,
1995). Several snRNA genes (U1, U2, and U3) are local-
ized adjacent to coiled bodies in a percentage of cases
(Frey and Matera, 1995; Smith et al., 1995; Gao et al.,
1997). Recently, LaMorte et al. (1998) have localized na-
scent RNA in coiled bodies, and a transcription factor,
TFIIH, was also detected in coiled bodies (Jordan and
Carmo-Fonseca, 1997). However, the exact function of
coiled bodies remains unknown. A second nuclear struc-
ture, “gems” (gemini of coiled body), was shown to be fre-
quently associated with coiled bodies (Liu and Dreyfuss,
1996). Gems contain the survival of motor neurons (SMN)
protein that is encoded by a gene responsible for spinal
muscular atrophy (Liu et al., 1997). The SMN protein was
shown to interact with snRNPs that are involved in pre-
mRNA splicing and with a cellular protein called SIP1
through a separate interaction (Liu et al., 1997). The
SMN–SIP1 complex was shown to be involved in snRNP
biogenesis (Fischer et al., 1997; Liu et al., 1997). PML bod-
ies, also named ND10 (nuclear domain 10) and POD
(PML oncogenic domains), change their number and size
in acute promyleocytic leukemia (Ascoli and Maul, 1991;
Dyck et al., 1994; Koken et al., 1994, 1995; Weis et al.,
1994; Terris et al., 1995; for review see Doucas and Evans,
1996). Generally, each cell nucleus contains z10–20 PML
bodies ranging from 0.3 to 1 mm in diameter. In acute
promyleocytic leukemia cells, PML bodies break up into a
large number of microparticulates (Dyck et al., 1994). Re-
cently, LaMorte et al. (1998) have localized nascent RNA
polymerase II transcripts and CREB binding protein to a
subset of PML bodies, suggesting that at least some PML
bodies are involved in transcription. Nuclear inclusions,
containing Huntington protein, are found in neurons in-
volved in Huntington’s Disease (Davies et al., 1997). Pa-
tients with Huntington’s Disease have an expanded NH2-
terminal polyglutamine region in Huntington, and its
length influences the extent of Huntington accumulation
within the intranuclear inclusions (DiFiglia et al., 1997).
The presence of ubiquitin in these structures suggests that
the abnormal Huntington is targeted for proteolysis (Di-
Figlia et al., 1997). Another recent example of a disease-
related nuclear inclusion is the change in the subnuclear
localization of the ataxin-1 protein, which is associatedThe Journal of Cell Biology, Volume 143, 1998 46
with the neurodegenerative disorder, Spinocerebellar ataxia
type I. The disease-related mutant ataxin-1, with an ex-
panded polyglutamine tract, localizes to a single z2-mm
structure compared with the normal ataxin-1 protein,
which localizes to several 0.5-mm nuclear structures (Skin-
ner et al., 1997). Ataxin-1 interacts with a cerebellar leu-
cine-rich acidic nuclear protein in a manner such that the
affinity of the association depends upon the number of
glutamines in mutant ataxin-1 (Matilla et al., 1997). All of
these examples demonstrate that nuclear structure is al-
tered in response to changes in cellular physiology and/or
pathology of cells or tissues. These changes may reflect
changes of nuclear function and/or regulation. Although
many nuclear bodies and inclusions have been described
morphologically, the functional relationship between many
of these structural changes and the respective diseases that
they are associated with are not clear. Our finding that the
PNC is potentially involved in transcription gives us an im-
portant clue to further address the molecular basis of the
PNC and its relationship with the transformed phenotype.
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